Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Fidelity Growth Strategies Fund's investment thesis on IDEXX Laboratories, Inc. ($IDXX) — Q4 2025 | Buyside Digest

All Pitches

View Letter Analysis

$IDXXNASDAQIDEXX Laboratories, Inc.

BULL

Fidelity Growth Strategies Fund—IDXX

Fund Letter

Q4 2025

Published December 31, 2025

View Fund Profile

$554.99USD

+3.7% vs last month

$669.99Pitched

-17.2% since pitch

Market Cap$46.1B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

For Q4 2025, the Fidelity Growth Strategies Fund returned -3.44%, slightly outperforming its benchmark, the Russell Midcap Growth Index, which returned -3.70%. The outperformance was...

— Shilpa Mehra

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $IDXX, and what else Fidelity Growth Strategies Fund is buying.

Other pitches on $IDXX

Other investors who've written on IDEXX Laboratories, Inc.

No other institutional pitches found for this ticker yet.

View all $IDXX pitches →